LITTLE KNOWN FACTS ABOUT LEAP-2.

however inactive from other host microbiota for example Actinobacteria or Bacteroidetes. Ibezapolstat was minimally absorbed within the hamster design, resulting in superior colonic and reduced systemic concentrations, and was also demonstrated to be successful for CDI.ten Preclinical basic safety tests shown a favourable safety profile.Hormonal co